The Role of Genetic Counselling in the Prevention and Management of Inborn Errors of Metabolism: A Review
DOI:
https://doi.org/10.67805/jaiim.v1i1.5Keywords:
inherited metabolic diseases, genetic counselling, neonatal screening, carrier screening, genetic testing, prenatal diagnosis, inherited metabolic disordersAbstract
Inborn errors of metabolism (IEMs) are a heterogenous set of inherited illnesses that occur due to abnormalities in enzymes, transport proteins, cofactors or other components of metabolic pathways. Rare separately, together IEMs contribute substantially to infant morbidity, developmental disability, neurological dysfunction, metabolic crises, organ damage and early mortality. Many IEMs are curable and early detection and immediate care can avert irreparable sequelae. Genetic counselling is a major component of the continuum of care for IEM, from preconception risk assessment and carrier discovery to newborn screening, molecular diagnosis, prenatal diagnosis, reproductive decision-making, therapeutic education, cascade testing and psychosocial support. Improvements in tandem mass spectrometry, next-generation sequencing, whole-exome sequencing, whole-genome sequencing, and metabolomics have promoted early detection and diagnosis. However, these technologies also pose issues in the interpretation of variants of unknown importance, informed consent, privacy, incidental results, affordability and equal access. These difficulties are especially pertinent in low- and middle-income countries, such as Nigeria, where newborn screening programs, specialised metabolic laboratories, genetic counselling services and access to treatment are still limited. Recent research from throughout Africa points to considerable variation in newborn screening and the need for integrated systems that link screening to confirmatory diagnosis, treatment, counselling and follow-up. The study highlights the significance of genetic counselling in the prevention and management of IEMs and methods for strengthening genetic and metabolic services in Nigeria and other resource-limited
Downloads
References
[1.]Zhang H, Tian H, Dai W, (2025). Expanded newborn screening for inborn errors of metabolism and genetic variants in Xinjiang, China. Frontiers in Genetics. 16:1617418.
[2.]Diagnosis of inborn errors of metabolism through massive DNA sequencing: Benefits and limitations, (2025). [Journal details not provided].
[3.]Famuyiwa MK, (2020). Congenital disorders and community genetic services in Nigeria: A systematic review. African Journal of Reproductive Health. 24(3):161–175.
[4.]Berry SA, (2021). Newborn screening and inherited metabolic disorders: Current perspectives. International Journal of Neonatal Screening. 7(4):72.
[5.]Ferreira CR, (2021). The burden of inherited metabolic diseases and advances in diagnosis. Journal of Inherited Metabolic Disease. 44(5):987–999.
[6.]Saudubray JM, Baumgartner MR, Walter JH, (2022). Inborn Metabolic Diseases: Diagnosis and Treatment. 7th ed. Springer.
[7.]Levy HL, (2020). Phenylketonuria: From newborn screening to lifelong management. Molecular Genetics and Metabolism. 131(1–2):1–8.
[8.]Anetor JI, Orimadegun BE, Anetor GO, (2023). A pragmatic approach to the diagnosis of inborn errors of metabolism in developing countries. African Journal of Laboratory Medicine. 12(1):1946.
[9.]Beck MM, Applegate CD, (2020). Genetic counseling and inherited metabolic disorders: Current practice and future directions. Journal of Genetic Counseling. 29(6):1025–1036.
[10.]Mak CM, Lee HC, Chan AY, Lam CW, (2013). Inborn errors of metabolism and expanded newborn screening: Review and update. Critical Reviews in Clinical Laboratory Sciences. 50(6):142–162.
[11.]Satekge T, Okesina A, Anetor J, Erasmus R, (2025). The status of newborn screening in Africa: Situation analysis, future plans and call to action. African Journal of Laboratory Medicine. 14(1):2973.
[12.]Folayan OS, Orimadegun BE, Ayede AI, Inusa BP, Kase MK, Anetor JI, (2026). Integrated newborn screening in Nigeria: The way forward, a workshop report. International Journal of Neonatal Screening. 12(1):5.
[13.]Vernon HJ, (2015). Inborn errors of metabolism: Advances in diagnosis and therapy. JAMA Pediatrics. 169(8):778–782.
[14.]van Rijt WJ, Koolhaas GD, Bekhof J, (2016). Inborn errors of metabolism that cause sudden infant death: A systematic review with implications for population neonatal screening programmes. Neonatology. 109(4):297–302.
[15.]Vockley J, Burton B, Berry GT, Longo N, Phillips J, Schiff M, (2021). Clinical management of inherited metabolic disorders. Molecular Genetics and Metabolism. 132(2):67–81.
[16.]Elmonem MA, van den Heuvel LP, (2021). Newborn screening for inborn errors of metabolism: Is it time for a globalized perspective based on genetic screening? Frontiers in Genetics. 12:758142.
[17.]Veldman A, Sikkema-Raddatz B, Derks TGJ,., (2025). Newborn screening by DNA-first: Systematic evaluation of the eligibility of inherited metabolic disorders based on treatability. International Journal of Neonatal Screening. 11(1).
[18.]Uppal K, (2024). Advances in reproductive genetics and preimplantation genetic testing for monogenic disorders. Human Reproduction Update. 30(1):45–67.
Published
Issue
Section
License
Copyright (c) 2026 Orji Deborah Chinonso (Author)

This work is licensed under a Creative Commons Attribution 4.0 International License.
Public Licensing Terms
Authors who publish with the Journal of AI and Integrative Medicine (JAIIM) agree to the following terms:
-
Authors retain copyright of their work and grant the Journal of AI and Integrative Medicine (JAIIM) the right of first publication.
-
Articles are published under the Creative Commons Attribution 4.0 International (CC BY 4.0) License, which permits unrestricted use, distribution, adaptation, and reproduction in any medium, provided the original author(s) and source are appropriately credited.
-
Authors may enter into separate, additional contractual arrangements for the non-exclusive distribution of the published version of the work (for example, depositing it in an institutional repository or including it in a book), provided that the original publication in the Journal of AI and Integrative Medicine (JAIIM) is acknowledged.
-
Authors are encouraged to post their submitted, accepted, and published versions of their work on institutional repositories, personal websites, and other scholarly platforms to increase visibility, dissemination, and citation, with appropriate acknowledgment of the Journal of AI and Integrative Medicine (JAIIM) as the original place of publication.
-
All articles published in this journal are immediately and permanently available as Open Access without subscription or access charges.
-
Users are free to read, download, copy, distribute, print, search, link to the full texts of articles, and use them for any lawful purpose in accordance with the terms of the Creative Commons Attribution 4.0 International License.


